Novartis (NVS) Tops Q4 EPS by 16c; offers guidance

Novartis (NYSE: NVS) reported Q4 EPS of $1.98, $0.16 better than the analyst estimate of $1.82. Revenue for the quarter came in at $13.15 billion versus the consensus estimate of $12.99 billion.

GUIDANCE

2025 Net sales expected to grow mid- to high-single digit and core operating income expected to grow high single to low double-digit.

For earnings history and earnings-related data on Novartis (NVS) click here.

You May Also Be Interested In

• Morgan Stanley upgrades CDW on stronger AI-driven server demand
• Increasing unusual put volume: AVGX WMB FJET EWA NASA BSX DFTX ACI TE BURL HSBC RIO WRBY OBDC GT DRAM
• Increasing unusual option volume: BLZE ADTN XYL BZFD DOMO IAG ARQQ PRIM USAS IVV ALLT RPD